Publications by authors named "Stephen Plymate"

Claim this Profile
A
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Takuma Uo, Kayode K Ojo, Cynthia C T Sprenger, Kathryn S Epilepsia, B Gayani K Perera, Stephen R Plymate

Mol Cancer Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
Jonathan L Wright, Jeannette M Schenk, Roman Gulati, Sarah J Beatty, Matthew VanDoren, Stephen R Plymate

Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.
Antje Neeb, Ines Figueiredo, Denisa Bogdan, Laura Cato, Jutta Stober, Stephen R Plymate

Mol Cancer Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
Zoi E Sychev, Abderrahman Day, Hannah E Bergom, Gabrianne Larson, Atef Ali, Stephen R Plymate

Mol Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.
Dong Han, Maryam Labaf, Yawei Zhao, Jude Owiredu, Songqi Zhang, Stephen R Plymate

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Takuma Uo, Kayode K Ojo, Cynthia C Sprenger, Kathryn Soriano Epilepsia, B Gayani K Perera, Stephen R Plymate

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer.
Antje Neeb, Ines Figueiredo, Bora Gurel, Daniel Nava Rodrigues, Jan Rekowski, Stephen R Plymate

Lab Invest· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Michael D Nyquist, Ilsa M Coleman, Jared M Lucas, Dapei Li, Brian Hanratty, Stephen R Plymate

Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The androgen receptor.
Greg Van-Duyne, Ian A Blair, Cynthia Sprenger, Vera Moiseenkova-Bell, Stephen Plymate

Vitam Horm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
Zoi E Sychev, Abderrahman Day, Hannah E Bergom, Gabrianne Larson, Atef Ali, Stephen R Plymate

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer.
Song Yi Bae, Hannah E Bergom, Abderrahman Day, Joseph T Greene, Zoi E Sychev, Stephen R Plymate

Front Endocrinol (Lausanne)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer.
Adam G Sowalsky, Stephen R Plymate, Michael C Haffner, Johann S de Bono, Adam Sharp

Eur Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer.
Stephen Y C Choi, Caroline Fidalgo Ribeiro, Yuzhuo Wang, Massimo Loda, Stephen R Plymate

Biomolecules· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, Ilsa Coleman, Bora Gurel, Stephen R Plymate

Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification.
Adam G Sowalsky, Adam Sharp, Shana Y Trostel, Johann S de Bono, Stephen R Plymate

Cancer Treat Res Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymes.
Stephen R Plymate, Cynthia Sprenger, Michael C Haffner

Cell Rep Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer.
Irfan Asangani, Ian A Blair, Gregory Van Duyne, Vincent J Hilser, Vera Moiseenkova-Bell, Stephen Plymate

J Biol Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
Michael D Nyquist, Lisa S Ang, Alexandra Corella, Ilsa M Coleman, Michael P Meers, Stephen R Plymate

J Clin Invest· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
Michael D Nyquist, Lisa S Ang, Alexandra Corella, Ilsa M Coleman, Michael P Meers, Stephen R Plymate

J Clin Invest· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.
Lauren Brady, Michelle Kriner, Ilsa Coleman, Colm Morrissey, Martine Roudier, Stephen R Plymate

Nat Commun· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.
Alec Paschalis, Jonathan Welti, Antje J Neeb, Wei Yuan, Ines Figueiredo, Stephen R Plymate

Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracrine androgen biosynthesis and drug resistance.
Trevor M Penning, Irfan A Asangani, Cynthia Sprenger, Stephen Plymate

Cancer Drug Resist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer.
Takuma Uo, Cynthia C Sprenger, Stephen R Plymate

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer.
Yingming Li, Rendong Yang, Christine M Henzler, Yeung Ho, Courtney Passow, Stephen R Plymate

Clin Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models.
Ulrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, Rosa Baumgartinger, Paul J Adam, Stephen R Plymate

Mol Cancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis